Co-Authors
This is a "connection" page, showing publications co-authored by Nadine Rouphael and Mark Mulligan.
Connection Strength
1.818
-
Microneedle patch for immunization of immunocompromised hosts. Oncotarget. 2017 Nov 07; 8(55):93311-93312.
Score: 0.739
-
Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood. Open Forum Infect Dis. 2019 Jan; 6(1):ofy352.
Score: 0.200
-
The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. Lancet. 2017 08 12; 390(10095):649-658.
Score: 0.181
-
Biphasic Zika Illness With Rash and Joint Pain. Open Forum Infect Dis. 2017; 4(3):ofx133.
Score: 0.180
-
Pericarditis Associated With Acute Zika Virus Infection in a Returning Traveler. Open Forum Infect Dis. 2017; 4(2):ofx103.
Score: 0.179
-
First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19. Clin Pharmacol Ther. 2021 12; 110(6):1467-1477.
Score: 0.061
-
Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans. J Virol. 2018 07 15; 92(14).
Score: 0.048
-
Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine. J Infect Dis. 2018 03 13; 217(7):1055-1059.
Score: 0.047
-
Innate, T-, and B-Cell Responses in Acute Human Zika Patients. Clin Infect Dis. 2018 01 06; 66(1):1-10.
Score: 0.047
-
Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine. 2018 01 29; 36(5):606-614.
Score: 0.047
-
Metabolic Phenotypes of Response to Vaccination in Humans. Cell. 2017 May 18; 169(5):862-877.e17.
Score: 0.045
-
Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial. Vaccine. 2017 03 23; 35(13):1675-1682.
Score: 0.044